Selected research
Market Analysis & Forecast
Global Personal Dose Monitoring Service Market Analysis and Forecast 2026-2032
Market perspective
The global Personal Dose Monitoring Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Personal Dose Monitoring Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Personal Dose Monitoring Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Personal Dose Monitoring Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Personal Dose Monitoring Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Personal Dose Monitoring Service include Landauer, Chiyoda Technol Corporation, Mirion Technologies, Thermo Fisher Scientific, Fuji Electric, XZ LAB, Sierra Radiation, PRS Dosimetry and Dosimetry Badge, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Personal Dose Monitoring Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Personal Dose Monitoring Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Personal Dose Monitoring Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Personal Dose Monitoring Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Personal Dose Monitoring Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Personal Dose Monitoring Service revenue, projected growth trends, production technology, application and end-user industry.
Personal Dose Monitoring Service Segment by Company
Landauer
Chiyoda Technol Corporation
Mirion Technologies
Thermo Fisher Scientific
Fuji Electric
XZ LAB
Sierra Radiation
PRS Dosimetry
Dosimetry Badge
Seibersdorf Labor
Radiation Detection Company
Personal Dose Monitoring Service Segment by Type
External Radiation Personal Dose Monitoring
Internal Radiation Personal Dose Monitoring
Personal Dose Monitoring Service Segment by Application
Medical
Scientific Research
Industry and Nuclear Power Plants
Others
Personal Dose Monitoring Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personal Dose Monitoring Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Personal Dose Monitoring Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personal Dose Monitoring Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Personal Dose Monitoring Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Personal Dose Monitoring Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personal Dose Monitoring Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- External Radiation Personal Dose Monitoring
- Internal Radiation Personal Dose Monitoring
Applications
- Medical
- Scientific Research
- Industry and Nuclear Power Plants
- Others
Companies covered
- Landauer
- Chiyoda Technol Corporation
- Mirion Technologies
- Thermo Fisher Scientific
- Fuji Electric
- XZ LAB
- Sierra Radiation
- PRS Dosimetry
- Dosimetry Badge
- Seibersdorf Labor
- Radiation Detection Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Personal Dose Monitoring Service Market by Type
- 1.2.1 Global Personal Dose Monitoring Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 External Radiation Personal Dose Monitoring
- 1.2.3 Internal Radiation Personal Dose Monitoring
- 1.3 Personal Dose Monitoring Service Market by Application
- 1.3.1 Global Personal Dose Monitoring Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Scientific Research
- 1.3.4 Industry and Nuclear Power Plants
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Personal Dose Monitoring Service Market Dynamics
- 2.1 Personal Dose Monitoring Service Industry Trends
- 2.2 Personal Dose Monitoring Service Industry Drivers
- 2.3 Personal Dose Monitoring Service Industry Opportunities and Challenges
- 2.4 Personal Dose Monitoring Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Personal Dose Monitoring Service Market Perspective (2021-2032)
- 3.2 Global Personal Dose Monitoring Service Growth Trends by Region
- 3.2.1 Global Personal Dose Monitoring Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Personal Dose Monitoring Service Market Size by Region (2021-2026)
- 3.2.3 Global Personal Dose Monitoring Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Personal Dose Monitoring Service Revenue by Players
- 4.1.1 Global Personal Dose Monitoring Service Revenue by Players (2021-2026)
- 4.1.2 Global Personal Dose Monitoring Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Personal Dose Monitoring Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Personal Dose Monitoring Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Personal Dose Monitoring Service Key Players Headquarters & Area Served
- 4.4 Global Personal Dose Monitoring Service Players, Product Type & Application
- 4.5 Global Personal Dose Monitoring Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Personal Dose Monitoring Service Market CR5 and HHI
- 4.6.3 2025 Personal Dose Monitoring Service Tier 1, Tier 2, and Tier 3
5 Personal Dose Monitoring Service Market Size by Type
- 5.1 Global Personal Dose Monitoring Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Personal Dose Monitoring Service Revenue by Type (2021-2032)
- 5.3 Global Personal Dose Monitoring Service Revenue Market Share by Type (2021-2032)
6 Personal Dose Monitoring Service Market Size by Application
- 6.1 Global Personal Dose Monitoring Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Personal Dose Monitoring Service Revenue by Application (2021-2032)
- 6.3 Global Personal Dose Monitoring Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Landauer
- 7.1.1 Landauer Company Information
- 7.1.2 Landauer Business Overview
- 7.1.3 Landauer Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Landauer Personal Dose Monitoring Service Product Portfolio
- 7.1.5 Landauer Recent Developments
- 7.2 Chiyoda Technol Corporation
- 7.2.1 Chiyoda Technol Corporation Company Information
- 7.2.2 Chiyoda Technol Corporation Business Overview
- 7.2.3 Chiyoda Technol Corporation Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Chiyoda Technol Corporation Personal Dose Monitoring Service Product Portfolio
- 7.2.5 Chiyoda Technol Corporation Recent Developments
- 7.3 Mirion Technologies
- 7.3.1 Mirion Technologies Company Information
- 7.3.2 Mirion Technologies Business Overview
- 7.3.3 Mirion Technologies Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Mirion Technologies Personal Dose Monitoring Service Product Portfolio
- 7.3.5 Mirion Technologies Recent Developments
- 7.4 Thermo Fisher Scientific
- 7.4.1 Thermo Fisher Scientific Company Information
- 7.4.2 Thermo Fisher Scientific Business Overview
- 7.4.3 Thermo Fisher Scientific Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Thermo Fisher Scientific Personal Dose Monitoring Service Product Portfolio
- 7.4.5 Thermo Fisher Scientific Recent Developments
- 7.5 Fuji Electric
- 7.5.1 Fuji Electric Company Information
- 7.5.2 Fuji Electric Business Overview
- 7.5.3 Fuji Electric Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Fuji Electric Personal Dose Monitoring Service Product Portfolio
- 7.5.5 Fuji Electric Recent Developments
- 7.6 XZ LAB
- 7.6.1 XZ LAB Company Information
- 7.6.2 XZ LAB Business Overview
- 7.6.3 XZ LAB Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.6.4 XZ LAB Personal Dose Monitoring Service Product Portfolio
- 7.6.5 XZ LAB Recent Developments
- 7.7 Sierra Radiation
- 7.7.1 Sierra Radiation Company Information
- 7.7.2 Sierra Radiation Business Overview
- 7.7.3 Sierra Radiation Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Sierra Radiation Personal Dose Monitoring Service Product Portfolio
- 7.7.5 Sierra Radiation Recent Developments
- 7.8 PRS Dosimetry
- 7.8.1 PRS Dosimetry Company Information
- 7.8.2 PRS Dosimetry Business Overview
- 7.8.3 PRS Dosimetry Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.8.4 PRS Dosimetry Personal Dose Monitoring Service Product Portfolio
- 7.8.5 PRS Dosimetry Recent Developments
- 7.9 Dosimetry Badge
- 7.9.1 Dosimetry Badge Company Information
- 7.9.2 Dosimetry Badge Business Overview
- 7.9.3 Dosimetry Badge Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Dosimetry Badge Personal Dose Monitoring Service Product Portfolio
- 7.9.5 Dosimetry Badge Recent Developments
- 7.10 Seibersdorf Labor
- 7.10.1 Seibersdorf Labor Company Information
- 7.10.2 Seibersdorf Labor Business Overview
- 7.10.3 Seibersdorf Labor Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Seibersdorf Labor Personal Dose Monitoring Service Product Portfolio
- 7.10.5 Seibersdorf Labor Recent Developments
- 7.11 Radiation Detection Company
- 7.11.1 Radiation Detection Company Company Information
- 7.11.2 Radiation Detection Company Business Overview
- 7.11.3 Radiation Detection Company Personal Dose Monitoring Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Radiation Detection Company Personal Dose Monitoring Service Product Portfolio
- 7.11.5 Radiation Detection Company Recent Developments
8 North America
- 8.1 North America Personal Dose Monitoring Service Revenue (2021-2032)
- 8.2 North America Personal Dose Monitoring Service Revenue by Type (2021-2032)
- 8.2.1 North America Personal Dose Monitoring Service Revenue by Type (2021-2026)
- 8.2.2 North America Personal Dose Monitoring Service Revenue by Type (2027-2032)
- 8.3 North America Personal Dose Monitoring Service Revenue Share by Type (2021-2032)
- 8.4 North America Personal Dose Monitoring Service Revenue by Application (2021-2032)
- 8.4.1 North America Personal Dose Monitoring Service Revenue by Application (2021-2026)
- 8.4.2 North America Personal Dose Monitoring Service Revenue by Application (2027-2032)
- 8.5 North America Personal Dose Monitoring Service Revenue Share by Application (2021-2032)
- 8.6 North America Personal Dose Monitoring Service Revenue by Country
- 8.6.1 North America Personal Dose Monitoring Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Personal Dose Monitoring Service Revenue by Country (2021-2026)
- 8.6.3 North America Personal Dose Monitoring Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Personal Dose Monitoring Service Revenue (2021-2032)
- 9.2 Europe Personal Dose Monitoring Service Revenue by Type (2021-2032)
- 9.2.1 Europe Personal Dose Monitoring Service Revenue by Type (2021-2026)
- 9.2.2 Europe Personal Dose Monitoring Service Revenue by Type (2027-2032)
- 9.3 Europe Personal Dose Monitoring Service Revenue Share by Type (2021-2032)
- 9.4 Europe Personal Dose Monitoring Service Revenue by Application (2021-2032)
- 9.4.1 Europe Personal Dose Monitoring Service Revenue by Application (2021-2026)
- 9.4.2 Europe Personal Dose Monitoring Service Revenue by Application (2027-2032)
- 9.5 Europe Personal Dose Monitoring Service Revenue Share by Application (2021-2032)
- 9.6 Europe Personal Dose Monitoring Service Revenue by Country
- 9.6.1 Europe Personal Dose Monitoring Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Personal Dose Monitoring Service Revenue by Country (2021-2026)
- 9.6.3 Europe Personal Dose Monitoring Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Personal Dose Monitoring Service Revenue (2021-2032)
- 10.2 China Personal Dose Monitoring Service Revenue by Type (2021-2032)
- 10.2.1 China Personal Dose Monitoring Service Revenue by Type (2021-2026)
- 10.2.2 China Personal Dose Monitoring Service Revenue by Type (2027-2032)
- 10.3 China Personal Dose Monitoring Service Revenue Share by Type (2021-2032)
- 10.4 China Personal Dose Monitoring Service Revenue by Application (2021-2032)
- 10.4.1 China Personal Dose Monitoring Service Revenue by Application (2021-2026)
- 10.4.2 China Personal Dose Monitoring Service Revenue by Application (2027-2032)
- 10.5 China Personal Dose Monitoring Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Personal Dose Monitoring Service Revenue (2021-2032)
- 11.2 Asia Personal Dose Monitoring Service Revenue by Type (2021-2032)
- 11.2.1 Asia Personal Dose Monitoring Service Revenue by Type (2021-2026)
- 11.2.2 Asia Personal Dose Monitoring Service Revenue by Type (2027-2032)
- 11.3 Asia Personal Dose Monitoring Service Revenue Share by Type (2021-2032)
- 11.4 Asia Personal Dose Monitoring Service Revenue by Application (2021-2032)
- 11.4.1 Asia Personal Dose Monitoring Service Revenue by Application (2021-2026)
- 11.4.2 Asia Personal Dose Monitoring Service Revenue by Application (2027-2032)
- 11.5 Asia Personal Dose Monitoring Service Revenue Share by Application (2021-2032)
- 11.6 Asia Personal Dose Monitoring Service Revenue by Country
- 11.6.1 Asia Personal Dose Monitoring Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Personal Dose Monitoring Service Revenue by Country (2021-2026)
- 11.6.3 Asia Personal Dose Monitoring Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Personal Dose Monitoring Service Revenue (2021-2032)
- 12.2 SAMEA Personal Dose Monitoring Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Personal Dose Monitoring Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Personal Dose Monitoring Service Revenue by Type (2027-2032)
- 12.3 SAMEA Personal Dose Monitoring Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Personal Dose Monitoring Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Personal Dose Monitoring Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Personal Dose Monitoring Service Revenue by Application (2027-2032)
- 12.5 SAMEA Personal Dose Monitoring Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Personal Dose Monitoring Service Revenue by Country
- 12.6.1 SAMEA Personal Dose Monitoring Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Personal Dose Monitoring Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Personal Dose Monitoring Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst